Radiopharmaceuticals Market Analysis 2026

Global Radiopharmaceuticals Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Radiopharmaceuticals Market Report Description

We have various report editions of Radiopharmaceuticals Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Radiopharmaceuticals Market Insights Video

Competitive Landscape of the Radiopharmaceuticals Market

The competitive landscape of the Radiopharmaceuticals market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized Radiopharmaceuticals companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

May 2023: Notable American pharmaceutical business NorthStar Medical Radioisotopes formed a strategic agreement with Inhibrx, Inc. This partnership's main goal is to jointly research and produce cutting-edge radiopharmaceuticals that are painstakingly made to fight cancer. This collaboration represents a major step forward in the advancement of cancer care since radiopharmaceuticals play a crucial role in the field of medical imaging, acting as a diagnostic and therapeutic tool for cancer. (Source: https://www.northstarnm.com/northstar-medical-radioisotopes-and-inhibrx-enter-into-collaboration-agreement-for-the-development-and-production-of-radiopharmaceutical-candidates/)

Top Companies Market Share in Radiopharmaceuticals Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Radiopharmaceuticals Market

Which Region Dominates the Radiopharmaceuticals Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. North America is witnessing an increase in the radiopharmaceuticals marketplace due to advancements in healthcare infrastructure, the growing prevalence of chronic sicknesses, and sturdy research and development sports. The area benefits from a strong regulatory framework, technological innovations in molecular imaging, and rising demand for customized medication. These elements contribute to increasing marketplace opportunities and funding in radiopharmaceuticals.

Which Region is Expanding at the Fastest CAGR?

Europe stands out as the fastest-growing region in the Radiopharmaceuticals market due to several compelling reasons. ? Europe's radiopharmaceuticals marketplace is expanding due to advancements in clinical imaging technology, growing healthcare expenditure, and growing incidences of chronic diseases. The location's sturdy emphasis on studies and development, coupled with supportive regulatory frameworks, fosters innovation and a marketplace boom. Growing adoption of PET and SPECT imaging techniques further drives demand for radiopharmaceuticals, positioning Europe as a big participant within the global marketplace.

 

The current report Scope analyzes Radiopharmaceuticals Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Radiopharmaceuticals Market Analysis

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 3250.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Radiopharmaceuticals market with a market size of USD 2564.31 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. The demand is amplified by the cancer prevalence.
• The Canada Radiopharmaceuticals market had a market share of USD 390.01 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. Canada's technological advancements.
• The Mexico Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 295.76 million in 2024.

Europe Radiopharmaceuticals Market Analysis

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 2437.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.

• The United Kingdom Radiopharmaceuticals market had a market share of USD 409.51 million in 2024 and is projected to grow at a CAGR of 10.1% during the forecast period. In the UK, Radiopharmaceuticals sales witness an upswing due to the regulatory approvals.
• The France Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 224.26 million in 2024.
• According to Cognitive Market Research, the Germany Radiopharmaceuticals market size was valued at USD 482.64 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. In Germany, Radiopharmaceuticals sales surged due to aging population.
• The Italy Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 209.63 million in 2024.
• The Russia Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 377.82 million in 2024.
• The Spain Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.4% during the forecast period with a market size of USD 199.88 million in 2024
• The Luxembourg Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 75.56 million in 2024.
• The Portugal Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 51.19 million in 2024.
• The Greece Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 29.25 million in 2024.
• Rest of Europe's Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 377.82 million in 2024.

Asia Pacific Radiopharmaceuticals Market Analysis

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1868.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Radiopharmaceuticals market size was valued at USD 840.96 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. Radiopharmaceuticals sales surge in China due to the diagnostic demand.
• The Japan Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 257.89 million in 2024.
• The India Radiopharmaceuticals market had a market share of USD 224.26 million in 2024 and is projected to grow at a CAGR of 14.6% during the forecast period. India's government funding.
• The South Korea Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 186.88 million in 2024.
• The Australia Radiopharmaceuticals market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 97.18 million in 2024.
• The South East Asia Radiopharmaceuticals market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 128.95 million in 2024.
• The Rest of Asia Pacific Radiopharmaceuticals market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 132.68 million in 2024.

South America Radiopharmaceuticals Market Analysis

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 406.26million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Radiopharmaceuticals market size was valued at USD 173.88 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. Radiopharmaceuticals sales flourish in Brazil due to the R&D investment.
• Argentina Radiopharmaceuticals market had a market share of USD 68.25 million in 2024 and is projected to grow at a CAGR of 11.1% during the forecast period. Argentina's nuclear medicine growth.
• Colombia Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.0% during the forecast period with a market size of USD 36.16 million in 2024.
• Peru Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.4% during the forecast period with a market size of USD 33.31 million in 2024.
• Chile Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.5% during the forecast period with a market size of USD 29.25 million in 2024.
• The Rest of Latin America Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 65.41 million in 2024.

Middle East Radiopharmaceuticals Market Analysis

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 162.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031

• The GCC Countries Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.3% during the forecast period with a market size of USD 69.55 million in 2024. Radiopharmaceuticals sales flourish due to the precision medicine.
• The Egypt Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 17.06 million in 2024.
• The South Africa Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 25.68 million in 2024. Radiopharmaceuticals sales flourish in South Africa due to the healthcare infrastructure.
• The Turkey Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 13.98 million in 2024.
• The Nigeria Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 17.06 million in 2024.
• The Rest of MEA Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 19.18 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.